Cellular Functions of Tissue Transglutaminase

International Review of Cell and Molecular Biology

Volumn 294, Issue , 2012, Pages 1-97

  Nurminskaya, Maria V ^a   Belkin, Alexey M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cell signaling; GTPase; Protein cross linking; Stem cells; Therapeutic target; Transamidation; Transglutaminase

Indexed keywords

ACYLTRANSFERASE INHIBITOR; ADENOSINE TRIPHOSPHATASE; CYSTAMINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; GELATINASE A; GPR56 PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; KCC 009; LACTADHERIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHOLIPASE C DELTA1; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN DISULFIDE ISOMERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN KINASE; SOMATOMEDIN BINDING PROTEIN 3; SYNDECAN 4; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; AUTOPHAGY; BINDING AFFINITY; BINDING SITE; BIOENGINEERING; CARTILAGE CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CYTOPLASM; DEAMINATION; DENDRITIC CELL; ENDOSOME; ENDOTHELIUM CELL; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEGRADATION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME RELEASE; EPIGENETICS; EPITHELIUM CELL; EXOCYTOSIS; EXTRACELLULAR MATRIX; FIBROBLAST; GENE REPRESSION; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUNTINGTON CHOREA; INTERNALIZATION; INTRACELLULAR SPACE; MACROPHAGE; MITOCHONDRIAL TARGETING SIGNAL; MITOCHONDRION; NEUTROPHIL; NONHUMAN; OLIGODENDROGLIA; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; STEM CELL; SUMOYLATION; TRANSCRIPTION REGULATION; TURNOVER TIME; UBIQUITINATION; VASCULAR SMOOTH MUSCLE;

EID: 84857427521     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394305-7.00001-X     Document Type: Chapter

References (409)

1. Achyuthan K.E., Greenberg C.S. Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J. Biol. Chem. 1987, 262:1901-1906.
2. Adams J.C., Lawler J. The thrombospondins. Int. J. Biochem. Cell Biol. 2004, 36:961-968.
3. Aeschlimann D., Paulsson M. Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J. Biol. Chem. 1991, 266:15308-15317.
4. Aeschlimann D., Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect. Tissue Res. 2000, 41:1-27.
5. Aeschlimann D., Paulsson M., Mann K. Identification of Gln726 in nidogen as the amine acceptor in transglutaminase-catalyzed cross-linking of laminin-nidogen complexes. J. Biol. Chem. 1992, 267:11316-11321.
6. Aeschlimann D., Wetterwald A., Fleisch H., Paulsson M. Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J. Cell Biol. 1993, 120:1461-1470.
7. Aeschlimann D., Mosher D., Paulsson M. Tissue transglutaminase and factor XIII in cartilage and bone remodeling. Semin. Thromb. Hemost. 1996, 22:437-443.
8. Agah A., Kyriakides T.R., Bornstein P. Proteolysis of cell-surface tissue transglutaminase by matrix metalloproteinase-2 contributes to the adhesive defect and matrix abnormalities in thrombospondin-2-null fibroblasts and mice. Am. J. Pathol. 2005, 167:81-88.
9. Ahn J.S., Kim M.K., Hahn J.H., Park J.H., Park K.H., Cho B.R., et al. Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 2008, 376:743-747.
10. Akar U., Ozpolat B., Mehta K., Fok J., Kondo Y., Lopez-Berestein G. Tissue transglutaminase inhibits autophagy in pancreatic cancer cells. Mol. Cancer Res. 2007, 5:241-249.
11. Akimov S.S., Belkin A.M. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 2001, 98:1567-1576.
12. Akimov S.S., Belkin A.M. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition. J. Cell Sci. 2001, 114:2989-3000.
13. Akimov S.S., Belkin A.M. Opposing roles of Ras/Raf oncogenes and the MEK1/ERK signaling module in regulation of expression and adhesive function of surface transglutaminase. J. Biol. Chem. 2003, 278:35609-35619.
14. Akimov S.S., Krylov D., Fleischman L.F., Belkin A.M. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J. Cell Biol. 2000, 148:825-838.
15. Alford S.C., Bazowski J., Lorimer H., Elowe S., Howard P.L. Tissue transglutaminase clusters soluble A-type ephrins into functionally active high molecular weight oligomers. Exp. Cell Res. 2007, 313:4170-4179.
16. Al-Jallad H.F., Nakano Y., Chen J.L., Mcmillan E., Lefebvre C., Kaartinen M.T. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. Matrix Biol. 2006, 25:135-148.
17. Al-Jallad H.F., Myneni V.D., Piercy-Kotb S.A., Chabot N., Mulani A., Keillor W., et al. Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics. PLoS One 2011, 6:e15893.
18. Antonyak M.A., Singh U.S., Lee D.A., Boehm J.E., Combs C., et al. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J. Biol. Chem. 2001, 276:33582-33587.
19. Antonyak M.A., Boehm J.E., Cerione R.A. Phosphoinositide 3-kinase activity is required for retinoic acid-induced expression and activation of the tissue transglutaminase. J. Biol. Chem. 2002, 277:14712-14716.
20. Antonyak M.A., Jansen J.M., Miller A.M., Ly T.K., Endo M., Cerione R.A. Two isoforms of tissue transglutaminase mediate opposing cellular fates. Proc. Natl. Acad. Sci. USA 2006, 103:18609-18614.
21. Antonyak M.A., Li B., Regan A.D., Feng Q., Dusabam S.S., Cerione R.A. Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion. J. Biol. Chem. 2009, 284:17914-17925.
22. Antonyak M.A., Li B., Boroughs L.K., Johnson J.L., Druso J.E., Bryant K.L., et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc. Natl. Acad. Sci. USA 2011, 108:4852-4857.
23. Arrighi I., Mark S., Alvisi M., von Rechenberg B., Hubbell J.A., Schense J.C. Bone healing induced by local delivery of an engineered parathyroid hormone. Biomaterials 2009, 30:1763-1771.
24. Baek K.J., Das T., Gray C., Antar S., Muruqesan G., Im M.J. Evidence that the Gh protein is a signal mediator from alpha 1-adrenoceptor to a phospholipase C. I. Identification of alpha 1-adrenoceptor-coupled Gh family and purification of Gh7 from bovine heart. J. Biol. Chem. 1993, 268:27390-27397.
25. Baek K.J., Das T., Gray C.D., Desai S., Hwang K.C., Gacchui R., et al. A 50 kDa protein modulates guanine nucleotide binding of transglutaminase II. Biochemistry 1996, 35:2651-2657.
26. Baek K.J., Kang S., Damron D., Im M.J. Phospholipase Cdelta1 is a guanine nucleotide exchanging factor for transglutaminase II (Galpha h) and promotes alpha 1B-adrenoreceptor-mediated GTP binding and intracellular calcium release. J. Biol. Chem. 2001, 276:5591-5597.
27. Bailey C.D., Tucholski J., Johnson G.V. Transglutaminases in neurodegenerative disorders. Prog. Exp. Tumor Res. 2005, 38:139-157.
28. Bakker E.N., Pistea A., VanBavel E. Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J. Vasc. Res. 2008, 45:271-278.
29. Balajthy Z., Csomos K., Vamosi G., Szanto A., Lanotte M., Fesus L. Tissue transglutaminase contributes to neutrophil granulocyte differentiation and functions. Blood 2006, 108:2045-2054.
30. Balint B.L., Szanto A., Madi A., Bauer U.M., Gabor P., Benko S., et al. Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells. Mol. Cell. Biol. 2005, 25:5648-5663.
31. Balklava Z., Verderio E., Collighan R., Gross S., Adams J., Griffin M. Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J. Biol. Chem. 2002, 277:16567-16575.
32. Ballestar E., Abad C., Franco L. Core histones are glutaminyl substrates for tissue transglutaminase. J. Biol. Chem. 1996, 271:18817-18824.
33. Ballestar E., Boix-Chornet M., Franco L. Conformational changes in the nucleosome followed by the selective accessibility of histone glutamines in the transglutaminase reaction: effects of ionic strength. Biochemistry 2001, 40:1922-1929.
34. Baron W., Decker L., Colognato H., ffrech-Constant C. Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr. Biol. 2003, 13:151-155.
35. Barsigian C., Fellin F.M., Jain A., Martinez J. Dissociation of fibrinogen and fibronectin binding from transglutaminase-mediated cross-linking at the hepatocyte surface. J. Biol. Chem. 1988, 263:14015-14022.
36. Barsigian C., Stern A.M., Martinez J. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators. J. Biol. Chem. 1991, 266:22501-22509.
37. Bass M.D., Morgan M.R., Roach K.A., Settleman J., Goryachev A.B., Humphries M.J. p190RhoGAP is the convergence point of adhesion signals from alpha 5 beta 1 integrin and syndecan-4. J. Cell Biol. 2008, 181:1013-1026.
38. Battaglia G., Farrace M.G., Mastroberardino P.G., Viti I., Fimia G.M., Van Beeumen J. Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders. J. Neurochem. 2007, 100:36-49.
39. Begg G.E., Holman S.R., Stokes P.H., Matthews J.M., Graham R.M., Iismaa S.E. Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity. J. Biol. Chem. 2006, 281:12603-12609.
40. Begg G.E., Carrington L., Stokes P.H., Matthews J.M., Wouters M.A., Housain A., et al. Mechanism of allosteric regulation of transglutaminase 2 by GTP. Proc. Natl. Acad. Sci. USA 2006, 103:19683-19688.
41. Belkin A.M. Extracellular TG2: emerging functions and regulation. FEBS J. 2011, PMID: 21902810.
42. Belkin A.M., Akimov S.S., Zaritskaya L.S., Ratnikov B.I., Deryugina E.I., Strongin A.Y. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J. Biol. Chem. 2001, 276:18415-18422.
43. Belkin A.M., Zemskov E.A., Hang J., Akimov S.S., Sikora S., Strongin A.Y. Cell surface-associated transglutaminase is a target of MMP-2 proteolysis. Biochemistry 2004, 43:11760-11769.
44. Belkin A.M., Tsurupa G., Zemskov E., Veklich Y., Weisel J.W., Medved L. Transglutaminase-mediated oligomerization of the fibrin(ogen) alphaC domains promotes integrin-dependent cell adhesion and signaling. Blood 2005, 105:3561-3568.
45. Beninati S., Senger D.R., Cordella-Miele E., Mukherjee A.B., Chackalaparampil I., Shanmugam V., et al. Osteopontin: its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin. J. Biochem. 1994, 115:675-682.
46. Bergamini C.M. Effects of ligands on the stability of tissue transglutaminase: studies in vitro suggest possible modulation by ligands of protein turn-over in vivo. Amino Acids 2007, 33:415-421.
47. Bernassola F., Federici M., Corazzari M., Terrinoni A., Hribal M.L., De Laurenzi V., et al. Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient. FASEB J. 2002, 16:1371-1378.
48. Blasko B., Madi A., Fesus L. Thioredoxin motif of Caenorhabditis elegans PDI-3 provides Cys and His catalytic residues for transglutaminase activity. Biochem. Biophys. Res. Commun. 2003, 303:1142-1147.
49. Boehm J.E., Singh U., Combs C., Antonyak M.A., Cerione R.A. Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J. Biol. Chem. 2002, 277:20127-20130.
50. Boisvert W.A., Rose D.M., Boullier A., Quehenberger O., Sydlaske A., Johnson K.A., et al. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler. Thromb. Vasc. Biol. 2006, 26:563-569.
51. Boros S., Ahrman E., Wunderink L., Kamps B., de Jong W.W., Boelens W.C., et al. Site-specific transamidation and deamidation of the small heat-shock protein Hsp20 by tissue transglutaminase. Proteins 2006, 62:1044-1052.
52. Boros S., Wilmarth P.A., Kamps B., de Jong W.W., Bloemendal H., Lampi K., et al. Tissue transglutaminase catalyzes the deamidation of glutamines in lens betaB(2)- and betaB(3)-crystallins. Exp. Eye Res. 2008, 86:383-393.
53. Boroughs L.K., Antonyak M.A., Johnson J.L., Cerione R.A. A unique role for heat shock protein 70 and its binding partner tissue transglutaminase in cancer cell migration. J. Biol. Chem. 2011, 286:37094-37107. PMID: 21896482.
54. Bowness J.M., Folk J.E., Timpl R.L. Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen. J. Biol. Chem. 1987, 262:1022-1024.
55. Briani C., Samaroo D., Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun. Rev. 2008, 7:644-650.
56. Caccamo D., Curro M., Condello S., Ferlazzo N., Lentile R. Critical role of transglutaminase and other stress proteins during neurodegenerative processes. Amino Acids 2010, 38:653-658.
57. Caccamo D., Curro M., Ferlazzo N., Condello S., Lentile R. Monitoring of transglutaminase 2 under different oxidative stress conditions. Amino Acids 2011, PMID: 21805137.
58. Cacciamani T., Virgili S., Centurelli M., Bertoli E., Eremenko T., Volpe P. Specific methylation of the CpG-rich domains in the promoter of the human tissue transglutaminase gene. Gene 2002, 297:103-112.
59. Campisi A., Renis M., Russo A., Sorrenti V., Di Giacomo C., Castorina C., et al. Transglutaminase activity in primary and subcultured rat astroglial cells. Neurochem. Res. 1992, 17:1201-1205.
60. Campisi A., Caccamo D., Raciti G., Cannavò G., Macaione V., Curro M., et al. Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells. Brain Res. 2003, 978:24-30.
61. Campisi A., Bramanti V., Caccamo D., Li Volti G., Cannavo G., Curro M. Effect of growth factors and steroids on transglutaminase activity and expression in primary astroglial cell cultures. J. Neurosci. Res. 2008, 86:1297-1305.
62. Cao L., Petrusca D.N., Satpathy M., Nakshatri H., Petrache I., Matei D. Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis 2008, 29:1893-1900.
63. Casadio R., Polverini E., Mariani P., Spinozzi F., Carsughi F., Fontana A., et al. The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur. J. Biochem. 1999, 262:672-679.
64. Caswell P.T., Vadrevu S., Norman J.C. Integrins: masters and slaves of endocytic transport. Nat. Rev. Mol. Cell Biol. 2009, 10:843-853.
65. Cecil D.L., Terkeltaub R. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes. J. Immunol. 2008, 180:8378-8385.
66. Chandrashekar R., Tsuji N., Morales T., Ozols V., Mehta K. An ERp60-like protein from the filarial parasite Dirofilaria immitis has both transglutaminase and protein disulfide isomerase activity. Proc. Natl. Acad. Sci. USA 1998, 95:531-536.
67. Chau D.Y., Collighan R.J., Verderio E.A., Addy V.L., Griffin M. The cellular response to transglutaminase-cross-linked collagen. Biomaterials 2005, 26:6518-6529.
68. Chen S., Lin F., Iismaa S., Lee K.N., Birckbichler P.J., Graham R.M. Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity. J. Biol. Chem. 1996, 271:32385-32391.
69. Chhabra A., Verma A., Mehta K. Tissue transglutaminase promotes or suppresses tumors depending on cell context. Anticancer Res. 2009, 29:1909-1919.
70. Chiocca E.A., Davies P.J., Stein J.P. Regulation of tissue transglutaminase gene expression as a molecular model for retinoid effects on proliferation and differentiation. J. Cell. Biochem. 1989, 39:293-304.
71. Cho S.Y., Lee J.H., Bae H.D., Jeong E.M., Jang G.Y., Kim C.W. Transglutaminase 2 inhibits apoptosis induced by calcium-overload through down-regulation of Bax. Exp. Mol. Med. 2010, 42:639-650.
72. Cho C.Y., Streets A.J., Watson P.F., Huang L., Verderio E.A., Johnson T.S. A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain. J. Biol. Chem. 2011, 286:27825-27835.
73. Choi K., Siegel M., Piper J.L., Yuan L., Cho E., Strnad P., et al. Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2. Chem. Biol. 2005, 12:469-475.
74. Chowdhury Z.A., Barsigian C., Chalupowicz G.D., Bach T.L., Garcia-Manero G., Martinez J. Colocalization of tissue transglutaminase and stress fibers in human vascular smooth muscle cells and human umbilical vein endothelial cells. Exp. Cell Res. 1997, 231:38-49.
75. Colak G., Keillor J.W., Johnson G.V. Cytosolic guanine nucleotide binding deficient form of transglutaminase 2 (R580A) potentiates cell death in oxygen glucose deprivation. PLoS One 2011, 6:e16665.
76. Collighan R.J., Griffin M. Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids 2009, 36:659-670.
77. Cooper A.J., Jeitner T.M., Blass J.P. The role of transglutaminases in neurodegenerative diseases: overview. Neurochem. Int. 2002, 40:53-67.
78. Coussons P.J., Price N.C., Kelly S.M., Smith B., Sawyer L. Factors that govern the specificity of transglutaminase-catalysed modification of proteins and peptides. Biochem. J. 1992, 282:929-930.
79. Cowan C.A., Henkemeyer M. Ephrins in reverse, park and drive. Trends Cell Biol. 2002, 12:339-346.
80. Csomos K., Nemet I., Fesus L., Balajthy Z. Tissue transglutaminase contributes to the all-trans-retinoic acid-induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia. Blood 2010, 116:3933-3943.
81. Csosz E., Bagossi P., Nagy Z., Dosztanyi Z., Simon I., Fesus L. Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination. J. Mol. Biol. 2008, 383:390-402.
82. D'Eletto M., Farrace M.G., Falasca L., Reali V., Oliverio S., Melino G. Transglutaminase 2 is involved in autophagosome maturation. Autophagy 2009, 5:1145-1154.
83. Dadabay C.Y., Pike L.J. Rapid increases in the transglutaminase activity of A431 cells following treatment with epidermal growth factor. Biochemistry 1987, 26:6587-6591.
84. Dafik L., Khosla C. Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2. Chem. Biol. 2011, 18:58-66.
85. Dai Y., Dudek N.L., Patel T.B., Muma N.A. Transglutaminase-catalyzed transamidation: a novel mechanism for Rac1 activation by 5-hydroxytryptamine 2A receptor stimulation. J. Pharmacol. Exp. Ther. 2008, 326:153-162.
86. Dardik R., Inbal A. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp. Cell Res. 2006, 16:2973-2982.
87. Das T., Baek K.J., Gray C., Im M.J. Evidence that the Gh protein is a signal mediator from α1-adrenoceptor to a phospholipase C. II. Purification and characterization of a Gh-coupled 69-kDa phospholipase C and reconstitution of α1-adrenoceptor, Gh family, and phospholipase C. J. Biol. Chem. 1993, 268:27390-27397.
88. Datta S., Antonuak M.A., Cerione R.A. GTP-binding-defective forms of tissue transglutaminase trigger cell death. Biochemistry 2007, 46:14819-14829.
89. De Laurenzi V., Melino G. Gene disruption of tissue transglutaminase. Mol. Cell. Biol. 2001, 21:148-155.
90. Deasey S., Grichenko O., Du S., Nurminskaya M. GTP-binding-defective forms of tissue transglutaminase trigger cell death. Amino Acids 2011, PMID: 21809079.
91. Dedeoglu A., Kubilus J.K., Jeitner T.M., Matson S.A., Bogdanov M., Kowall N.W., et al. Therapeutic effects of cystamine in a murine model of Huntington's disease. J. Neurosci. 2002, 22:8942-8950.
92. DeMali K.A., Balciunaite E., Kazlauskas A. Integrins enhance platelet-derived growth factor (PDGF)-dependent responses by altering the signal relay enzymes that are recruited to the PDGF beta receptor. J. Biol. Chem. 1999, 274:19551-19558.
93. Di Venere A., Rossi A., De Matteis F., Rosato N., Agro A.F., Mei G. Opposite effects of Ca(2+) and GTP binding on tissue transglutaminase tertiary structure. J. Biol. Chem. 2000, 275:3915-3921.
94. Dierker T., Dreier R., Migone M., Hamer S., Grobe K. Heparan sulfate and transglutaminase activity are required for the formation of covalently cross-linked hedgehog oligomers. J. Biol. Chem. 2009, 284:32562-32571.
95. D'Souza D.R., Wei J., Shao Q., Hebert M.D., Subramony S.H., Vig P.J. Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis. Neurosci. Lett. 2006, 409:5-9.
96. Dupuis M., Levy A., Mhaouty-Kodja S. Functional coupling of rat myometrial alpha 1-adrenergic receptors to Gh alpha/tissue transglutaminase 2 during pregnancy. J. Biol. Chem. 2004, 279:19257-19263.
97. Dyer L.M., Schooler K.P., Ai L., Klop C., Qiu J., Robertson K.D. The transglutaminase 2 gene is aberrantly hypermethylated in glioma. J. Neurooncol 2011, 101:429-440.
98. Elli L., Bergamini C.M., Bardella M.T., Schuppan D. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Dig. Liver Dis. 2009, 41:541-550.
99. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
100. Esposito C., Caputo I. Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. FEBS J. 2005, 272:615-631.
101. Esposito C., Marra M., Giuberti G., D'Alessandro A.M., Porta R., Cozzolino A., et al. Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells. Biochem. J. 2003, 370:205-212.
102. Facchiano A., Facchiano F. Transglutaminases and their substrates in biology and human diseases: 50 years of growing. Amino Acids 2009, 36:599-614.
103. Falasca L., Iadevaia V., Ciccosanti F., Melino G., Serafino A., Piacentini M. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment. J. Immunol. 2005, 174:7330-7340.
104. Faverman L., Mikhaylova L., Malmquist J., Nurminskaya M. Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett. 2008, 582:1552-1557.
105. Faye C., Inforzato A., Bignon M., Hartmann D.J., Muller L., Ballut L., et al. Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells. Biochem. J. 2010, 427:467-475.
106. Feng J.F., Rhee S.G., Im M.J. Evidence that phospholipase δ1 is the effector in the Gh (transglutaminase II)-mediated signaling. J. Biol. Chem. 1996, 271:16451-16454.
107. Feng J.F., Gray C., Im M.J. α1B-adrenoceptor interacts with multiple sites of transglutaminase II: characteristics of the interaction in binding and activation. Biochemistry 1999, 38:2224-2232.
108. Feng J.F., Readson M., Yadav S.P., Im M.J. Calreticulin downregulates both GTP binding and transglutaminase activities of transglutaminase II. Biochemistry 1999, 38:10743-10749.
109. Festoff B.W., SantaCruz K., Arnold P.M., Sebastian C.T., Davies P.J., Citron B.A. Injury-induced " switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord. J. Neurochem. 2002, 81:708-718.
110. Fesus L. Apoptosis. Immunol. Today 1992, 13:A16-A17.
111. Fesus L., Szondy Z. Transglutaminase 2 in the balance of cell death and survival. FEBS Lett. 2005, 579:3297-3302.
112. Fesus L., Tarcsa E. Formation of N epsilon-(gamma-glutamyl)-lysine isodipeptide in Chinese hamster ovary cells. Biochem. J. 1989, 263:843-848.
113. Fesus L., Falus A., Erdei A., Laki K. Human beta 2-microglobulin is a substrate of tissue transglutaminase: polymerization in solution and on the cell surface. J. Cell Biol. 1981, 89:706-710.
114. Fesus L., Horvath A., Harsfalvi J. Interaction between tissue transglutaminase and phospholipid vesicles. FEBS Lett. 1983, 155:1-5.
115. Filiano A.J., Bailey C.D., Tucholski J., Gundemir S., Johnson G.V. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling. FASEB J. 2008, 22:2662-2675.
116. Fisher M., Jones R.A., Huang L., Haylor J.L., El Nahas M., Griffin M., et al. Modulation of tissue transglutaminase in tubular epithelial cells alters extracellular matrix levels: a potential mechanism of tissue scarring. Matrix Biol. 2009, 28:20-31.
117. Fleckenstein B., Qiao S.W., Larsen M.R., Jung G., Roepstorff P., Sollid L.M. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J. Biol. Chem. 2004, 279:17607-17616.
118. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311:83-87.
119. Folk J.E. Transglutaminases. Annu. Rev. Biochem. 1980, 49:517-531.
120. Fornelli L., Schmid A.W., Grasso L., Vogel H., Tsybin Y.O. Deamidation and transamidation of substance P by tissue transglutaminase revealed by electron-capture dissociation fourier transform mass spectrometry. Chemistry 2011, 17:486-497.
121. Forsprecher J., Wang Z., Nelea V., Kaartinen M.T. Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin. Amino Acids 2009, 36:747-753.
122. Forsprecher J., Wang Z., Goldberg H.A., Kaartinen M.T. Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein. Cell Adh. Migr. 2011, 5:65-72.
123. Fraij B.M. Activation of tissue tranglutsaminase by removal of carboxyl-terminal peptides. J. Cell. Biochem. 2011, 112:3469-3481. PMID: 21769919.
124. Fraij B.M., Gonzales R.A. A third human tissue transglutaminase homologue as a result of alternative gene transcripts. Biochim. Biophys. Acta 1996, 1306:63-74.
125. Fraij B.M., Birckbichler P.J., Patterson M.K., Lee K.N., Gonzales R.A. A retinoic acid-inducible mRNA from human erythroleukemia cells encodes a novel tissue transglutaminase homologue. J. Biol. Chem. 1992, 267:22616-22623.
126. Fuchshofer R., Birke M., Welge-Lussen U., Kook D., Lutjen-Drecoll E. Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest. Ophthalmol. Vis. Sci. 2005, 46:568-578.
127. Gaudry C.A., Verderio E., Jones R.A., Smith C., Griffin M. Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin. Exp. Cell Res. 1999, 252:104-113.
128. Gentile V., Saydak M., Chiocca E.A., Akande O., Birckbichler P.J., Lee K.N., et al. Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J. Biol. Chem. 1991, 266:478-483.
129. Gentile V., Thomazy V., Piacentini M., Fesus L., Davies P.J. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cell morphology and adhesion. J. Cell Biol. 1992, 119:463-474.
130. Gentile V., Porta R., Chiosi E., Spina A., Valente F., Pezone R., et al. TGase/Gah protein expression inhibits adenylate cyclase activity in Balb-C 3T3 fibroblasts membranes. Biochim. Biophys. Acta 1997, 1357:115-122.
131. George M.D., Vollberg T.M., Floyd E.E., Stein J.P., Jetten A.M. Regulation of transglutaminase type II by transforming growth factor-beta 1 in normal and transformed human epidermal keratinocytes. J. Biol. Chem. 1990, 265:11098-11104.
132. Ghanta K.S., Pakala S.B., Reddy S.D., Li D.Q., Nair S.S., Kumar R. MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response. J. Biol. Chem. 2011, 286:7132-7138.
133. Giandomenico V., Lancillotti F., Fiorucci G., Percario Z.A., Rivabene R., Malorni W., et al. Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways. Cell Growth Differ. 1997, 8:91-100.
134. Glass W.F., Briggs J.A., Meredith M.J., Briggs R.C., Hnilica L.S. Enzymatic modification of Novikoff hepatoma lamins A and C. J. Biol. Chem. 1985, 260:1895-1900.
135. Gorman J.J., Folk J.E. Transglutaminase amine substrates for photochemical labeling and cleavable cross-linking of proteins. J. Biol. Chem. 1980, 255:1175-1180.
136. Gorman J.J., Folk J.E. Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme. J. Biol. Chem. 1984, 259:9007-9010.
137. Grenard P., Bates M.K., Aeschlimann D. Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z. J. Biol. Chem. 2001, 276:33066-33078.
138. Griffin M., Casadio R., Bergamini C.M. Transglutaminases: nature's biological glues. Biochem. J. 2002, 368:377-396.
139. Gruber C.W., Cemazar M., Heras B., Martin J.L., Craik D.J. Protein disulfide isomerase: the structure of oxidative folding. Trends Biochem. Sci. 2006, 31:455-464.
140. Guilluy C., Rolli-Derkinderen M., Tharaux P.L., Melino G., Pacaud P., Loirand G. Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J. Biol. Chem. 2007, 282:2918-2928.
141. Guilluy C., Eddahibi S., Agard C., Guignabert C., Izikki M., Tu L., et al. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Am. J. Respir. Crit. Care Med. 2009, 179:1151-1158.
142. Gundemir S., Johnson G.V. Intracellular localization and conformational state of transglutaminase 2: implications for cell death. PLoS One 2009, 4:e6123.
143. Haddox M.K., Russel D.H. Increased nuclear conjugated polyamines and transglutaminase during liver regeneration. Proc. Natl. Acad. Sci. USA 1981, 78:1712-1716.
144. Han J.A., Park S.C. Transglutaminase-dependent modulation of transcription factor Sp1 activity. Mol. Cells 2000, 10:612-618.
145. Han B.G., Cho J.W., Cho Y.D., Jeong K.C., Kim S.Y., Lee B.I., et al. Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate. Int. J. Biol. Macromol. 2010, 47:190-195.
146. Hand D., Perry M.J., Haynes L.W. Cellular transglutaminases in neural development. Int. J. Dev. Neurosci. 1993, 11:709-720.
147. 2 -terminal beta-sandwich domain of tissue transglutaminase. J. Biol. Chem. 2005, 280:23675-23683.
148. Harsfalvi J., Arato G., Fesus L. Lipids associated with tissue transglutaminase. Biochim. Biophys. Acta 1987, 923:42-45.
149. Harsfalvi J., Tarcsa E., Udvardy M., Zajka G., Szarvas T., Fesus L. Presence and possible origin of epsilon(gamma-glutamyl)lysine isodipeptide in human plasma. Thromb. Haemost. 1992, 67:60-62.
150. Hasegawa G., Suwa M., Ichikawa Y., Ohtsuka T., Kumagai S., Kikuchi M., et al. A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem. J. 2003, 373:793-803.
151. Heath D.J., Downes S., Verderio E., Griffin M. Characterization of tissue transglutaminase in human osteoblast-like cells. J. Bone Miner. Res. 2001, 16:1477-1485.
152. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999, 79:1283-1316.
153. Herman J.F., Mangala L.S., Mehta K. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene 2006, 25:3049-3058.
154. Hettasch J.M., Peoples K.A., Greenberg C.S. Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras. J. Biol. Chem. 1997, 272:25149-25156.
155. Higashikawa F., Eboshida A., Yokosaki Y. Enhanced biological activity of polymeric osteopontin. FEBS Lett. 2007, 581:2697-2701.
156. Hitomi K., Kitamura M., Sugimura Y. Preferred substrate sequences for transglutaminase 2: screening using a phage-displayed peptide library. Amino Acids 2009, 36:619-624.
157. Hu B.H., Messersmith P.B. Enzymatically cross-linked hydrogels and their adhesive strength to biosurfaces. Orthod. Craniofac. Res. 2005, 8:145-149.
158. Huang L., Haylor J.L., Hau Z., Jones R.A., Vickers M.E., Wagner B., et al. Transglutaminase inhibition ameliorates experimental diabetic nephropathy. Kidney Int. 2009, 76:383-394.
159. Hwang K.C., Gray C.D., Sivasubramanian N., Im M.J. Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C. J. Biol. Chem. 1995, 270:27058-27062.
160. Ientile R., Caccamo D., Griffin M. Tissue transglutaminase and the stress response. Amino Acids 2007, 33:385-394.
161. Iismaa S.E., Chung L., Wu M.J., Teller D.C., Yee V.C., Graham R.M. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP. Biochemistry 1997, 36:11655-11664.
162. Iismaa S.E., Holman S., Wouters M.A., Lorand L., Graham R.M., Husain A. Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases. Proc. Natl. Acad. Sci. USA 2003, 100:12636-12641.
163. Iismaa S.E., Mearns B.M., Lorand L., Graham R.M. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol. Rev. 2009, 89:991-1023.
164. Im M.J., Graham R.M. A novel guanine nucleotide-binding protein coupled to the α1-adrenergic receptor. I. Identification by photolabeling of membrane and ternary complex preparations. J. Biol. Chem. 1990, 265:18952-18960.
165. Im M.J., Riek R.P., Graham R.M. A novel guanine nucleotide-binding protein coupled to the α1-adrenergic receptor. II. Purification, characterization and reconstitution. J. Biol. Chem. 1990, 265:18952-18960.
166. Itoh M., Kawamoto T., Tatsukawa H., Kojima S., Yamanishi K., Hitomi K. In situ detection of active transglutaminases for keratinocyte type (TGase 1) and tissue type (TGase 2) using fluorescence-labeled highly reactive substrate peptides. J. Histochem. Cytochem. 2011, 59:180-187.
167. Jang G.Y., Jeon J.H., Cho S.Y., Shin D.M., Kim C.W., Jeong E.M., et al. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells. Oncogene 2010, 29:356-367.
168. Janiak A., Zemskov E.A., Belkin A.M. Cell surface transglutaminase induces RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol. Biol. Cell 2006, 17:1606-1619.
169. Jeitner T.M., Pinto J.T., Krasnikov B.F., Horswill M., Cooper A.J. Transglutaminases and neurodegeneration. J. Neurochem. 2009, 109:160-166.
170. Jeong E.M., Kim C.W., Cho S.Y., Jang G.Y., Shin D.M., Jeon J.H., et al. Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress. FEBS Lett. 2009, 583:648-654.
171. Jin X., Stamnaes J., Kloeck C., Diraimondo T.R., Sollid L.M., Khosla C. Activation of extracellular transglutaminase 2 by thioredoxin. J. Biol. Chem. 2011, 286:37866-37873. PMID: 21908620.
172. Johnson K.A., Terkeltaub R.A. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J. Biol. Chem. 2005, 280:15004-15012.
173. Johnson T.S., Scholfield C.I., Parry J., Griffin M. Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas. Biochem. J. 1998, 331:105-112.
174. Johnson K., Hashimoto S., Lotz M., Pritzker K., Terkeltaub R. Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am. J. Pathol. 2001, 159:149-163.
175. Johnson K.A., van Etten D., Nanda N., Graham R.M., Terkeltaub R.A. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy. J. Biol. Chem. 2003, 278:18824-18832.
176. Johnson T.S., Fisher M., Haylor J.L., Hau Z., Skill N.J., et al. Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. J. Am. Soc. Nephrol. 2007, 18:3078-3088.
177. Johnson K.A., Polewski M., Terkeltaub R.A. Transglutaminase 2 is central to induction of arterial calcification program. Circ. Res. 2008, 102:529-537.
178. Johnson K.A., Rose D.M., Terkeltaub R.A. Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation. J. Cell Sci. 2008, 121:2256-2264.
179. Johnson K.B., Thompson J.M., Watts S.W. Modification of proteins by norepinephrine is important for vascular contraction. Front. Physiol. 2010, 1:131.
180. Jones R.A., Kotsakis P., Johnson T.S., Chau D.Y., Ali S., Melino G. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ. 2006, 13:1442-1453.
181. Jung S.A., Lee H.K., Yoon J.S., Kim S.J., Kim C.Y., Song H., et al. Upregulation of TGF-beta-induced tissue transglutaminase expression by PI3K-Akt pathway activation in human subconjunctival fibroblasts. Invest. Ophthalmol. Vis. Sci. 2007, 48:1952-1958.
182. Junn E., Ronchetti R.D., Quezado M.M., Kim S.Y., Mouradian M.M. Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA 2003, 100:2047-2052.
183. Jurgensen K., Aeschlimann D., Cavin V., Genge M., Hunziker E.B. A new biological glue for cartilage-cartilage interfaces: tissue transglutaminase. J. Bone Joint Surg. Am. 1997, 79:185-193.
184. Kahlem P., Green H., Djian P. Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. Mol. Cell 1998, 1:595-601.
185. 2+ via a1B-adrenoceptor signaling molecules, Gah (transglutaminase II) and phospholipase C-d1. Biochem. Biophys. Res. Commun. 2002, 293:383-390.
186. Kang S.K., Yi K.S., Kwon N.S., Park K.H., Kim U.H., Baek K.J., et al. Alpha1B-adrenoceptor signaling and cell motility: GTPase function of Gh/transglutaminase 2 inhibits cell migration through interaction with cytoplasmic tail of integrin alpha subunits. J. Biol. Chem. 2004, 279:36593-36600.
187. Karpuj M.V., Garren H., Slunt H., Price D.L., Gusella J., Becher M.W., et al. Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. Proc. Natl. Acad. Sci. USA 1999, 96:7388-7393.
188. Karpuj M.V., Becher M.W., Springer J.E., Chabas D., Youssef S., Pedotti R., et al. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat. Med. 2002, 8:143-149.
189. Keresztessy Z., Csosz E., Harsfalvi J., Csomos K., Gray J., Lightowlers R.N., et al. Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2. Protein Sci. 2006, 15:2466-2480.
190. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
191. Khanna M., Chelladurai B., Gavini A., Li L., Shao M., Courtney D., et al. Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase. Mol. Cancer Ther. 2011, 10:626-636.
192. Khew S.T., Yang Q.J., Tong Y.W. Enzymatically crosslinked collagen-mimetic dendrimers that promote integrin-targeted cell adhesion. Biomaterials 2008, 29:3034-3045.
193. Khew S.T., Panengad P.P., Raghunath M., Tong Y.W. Characterization of amine donor and acceptor sites for tissue type transglutaminase using a sequence from the C-terminus of human fibrillin-1 and the N-terminus of osteonectin. Biomaterials 2010, 31:4600-4608.
194. Kim S.Y. Transglutaminase 2 in inflammation. Front. Biosci. 2006, 11:3026-3035.
195. Kim S.Y., Marekov L., Bubber P., Browne S.E., Stavrovskaya I., Lee J., et al. Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain. Neurochem. Res. 2005, 30:1245-1255.
196. Kim Y., Eom S., Kim K., Lee Y.S., Choe J., Hahn J.H., et al. Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation. Mol. Immunol. 2010, 47:1010-1022.
197. Kinberger G.A., Cai W., Goodman M. Collagen mimetic dendrimers. J. Am. Chem. Soc. 2002, 124:15162-15163.
198. Kiraly R., Csosz E., Kurtan T., Antus S., Szigeti K., Simon-Vecsei Z., et al. Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis. FEBS Lett. 2009, 276:7083-7096.
199. Kiraly R., Demeny M., Fesus L. Protein transamidation by transglutaminase 2 in cells: a disputed Ca(2+)-dependent action of a multifunctional protein. FEBS J. 2011, PMID: 21902809.
200. Kleman J.P., Aeschlimann D., Paulsson M., van der Rest M. Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry 1995, 34:13768-13775.
201. Kojima S., Nara K., Rifkin D.B. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J. Cell Biol. 1993, 121:439-448.
202. Kojima S., Inui T., Muramatsu H., Suzuki Y., Kadomatsu K., Yoshizawa M., et al. Dimerization of midkine by tissue transglutaminase and its functional implication. J. Biol. Chem. 1997, 272:9410-9416.
203. Kumar A., Xu J., Brady S., Gao H., Yu D., Reuben J., et al. Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells. PLoS One 2010, 5:e13390.
204. Kumar A., Gao H., Xu J., Reuben J., Yu D., Mehta K. Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cells. PLoS One 2011, 6:e20701.
205. Kuncio G.S., Tsyganskaya M., Zhu J., Liu S.L., Nagy L., Thomazy V., et al. TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. Am. J. Physiol. 1998, 274:G240-G245.
206. Kunioka Y., Ando T. Innocuous labeling of the subfragment-2 region of skeletal muscle heavy meromyosin with a fluorescent polyacrylamide nanobead and visualization of individual heavy meromyosin molecules. J. Biochem. 1996, 119:1024-1032.
207. Lai T.S., Slaughter T.F., Koropchak C.M., Haroon Z.A., Greenberg C.S. C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/ATPase activity. J. Biol. Chem. 1996, 271:31191-31195.
208. Lai T.S., Bielawska A., Peoples K.A., Hannun Y.A., Greenberg C.S. Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase. J. Biol. Chem. 1997, 272:16295-16300.
209. Lai T.S., Slaughter T.F., Peoples K.A., Hettasch J.M., Greenberg C.S. Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J. Biol. Chem. 1998, 273:1776-1781.
210. Lai T.S., Hausladen A., Slaughter T.F., Eu J.P., Stamler J.S., Greenberg C.S. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 2001, 40:4904-4910.
211. Lai T.S., Liu Y., Li W., Greenberg C.S. Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells. FASEB J. 2007, 21:4131-4143.
212. Lai T.S., Davies C., Greenberg C.S. Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation. Protein Sci. 2010, 19:229-235.
213. Larreta-Garde V., Berry H. Modeling extracellular matrix degradation balance with proteinase/transglutaminase cycle. J. Theor. Biol. 2002, 217:105-124.
214. + channel by Gαh (transglutaminase II) in the vascular smooth muscle cell. Eur. J. Physiol. 1997, 433:671-673.
215. Lee K.H., Lee N., Lim S., Jung H., Ko Y.G., Park H.Y., et al. Calreticulin inhibits the MEK1,2-ERK1,2 pathway in α1-adrenergic receptor/Gh-stimulated hypertrophy of neonatal rat cardiomyocytes. J. Steroid Biochem. Mol. Biol. 2003, 84:101-107.
216. Leiss M., Beckmann K., Giros A., Costell M., Fassler R. The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr. Opin. Cell Biol. 2008, 314:3444-3452.
217. Lentini A., Tabolacci C., Melino S., Provenzano B., Beninati S. Post-translational modification of glutamine and lysine residues of HIV-1 aspartyl protease by transglutaminase increases its catalytic activity. Biochem. Biophys. Res. Commun. 2010, 393:546-550.
218. Leroy P., Berto F., Bourget I., Rossi B. Down-regulation of Hox A7 is required for cell adhesion and migration on fibronectin during early HL-60 monocytic differentiation. J. Leukoc. Biol. 2004, 75:680-688.
219. Lesort M., Attanavanich K., Zhang J., Johnson G.V. Distinct nuclear localization and activity of tissue transglutaminase. J. Biol. Chem. 1998, 273:11991-11994.
220. Lesort M., Lee M., Tucholski J., Johnson G.V. Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J. Biol. Chem. 2003, 278:3825-3830.
221. Lewis T.E., Milam T.D., Klingler D.W., Rao P.S., Jaggi M., Smith D.J., et al. Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer. Urol. Oncol. 2005, 23:407-412.
222. L'Heureux D.Z., Rothman V.L., Tuszynski G.P. The interaction of angiocidin with tissue transglutaminase. Exp. Mol. Pathol. 2010, 88:15-25.
223. Li X., Wei X.L., Meng L.L., Chi M.G., Yan J.Q., Ma X.Y., et al. Involvement of tissue transglutaminase in endothelin 1-induced hypertrophy in cultured neonatal rat cardiomyocytes. Hypertension 2009, 54:839-844.
224. Li B., Antonyak M.A., Druso J.E., Cheng L., Nikitin A.Y., Cerione R.A. EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Proc. Natl. Acad. Sci. USA 2010, 107:1408-1413.
225. Li Z., Xu X., Bai L., Chen W., Lin Y. Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells. J. Biol. Chem. 2011, 286:21164-21172.
226. Lin Y.F., Yeh T.S., Chen S.F., Tsai Y.H., Chou C.M., Yang Y.Y., et al. Nonmuscle myosin IIA (myosin heavy polypeptide 9): a novel class of signal transducer mediating the activation of G alpha h/phospholipase C-delta 1 pathway. Endocrinology 2010, 151:876-885.
227. Liu S., Cerione R.A., Clardy J. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc. Natl. Acad. Sci. USA 2002, 99:2743-2747.
228. Liu T., Tee A.E., Porro A., Smith S.A., Dwarte T., Liu P.Y., et al. Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proc. Natl. Acad. Sci. USA 2007, 104:18682-18687.
229. Liu Y., Wei L., Laskin D.L., Fanburg B.L. Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 2011, 44:548-555.
230. Lorand L., Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 2003, 4:140-156.
231. Lorand L., Weissmann L.B., Epel D.L., Bruner-Lorand J. Role of the intrinsic transglutaminase in the Ca2+-mediated crosslinking of erythrocyte proteins. Proc. Natl. Acad. Sci. USA 1976, 73:4479-4481.
232. Lorand L., Murthy S.N., Velasco P.T., Karush F. Identification of transglutaminase substrates in inside-out vesicles from human erythrocytes: immunoblotting with anti-dansyl antibody. Biochem. Biophys. Res. Commun. 1986, 134:685-689.
233. Lorand L., Barnes N., Bruner-Lorand J.A., Hawkins M., Michalska M. Inhibition of protein cross-linking in Ca2+-enriched human erythrocytes and activated platelets. Biochemistry 1987, 26:308-313.
234. Lu S., Davies P.J. Regulation of the expression of the tissue transglutaminase gene by DNA methylation. Proc. Natl. Acad. Sci. USA 1997, 94:4692-4697.
235. Lu S., Saydak M., Gentile V., Stein J.P., Davies P.J. Isolation and characterization of the human tissue transglutaminase gene promoter. J. Biol. Chem. 1995, 270:9748-9756.
236. Luciani A., Villella V.R., Vasaturo A., Giardino I., Raia V., Pettoello-Mantovani M., et al. SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation. J. Immunol. 2009, 183:2775-2784.
237. Luciani A., Villella V.R., Esposito S., Brunetti-Pierri N., Medina D., Settembre C., et al. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat. Cell Biol. 2010, 12:863-875.
238. Maccioni R.B., Seeds N.W. Transglutaminase and neuronal differentiation. Mol. Cell. Biochem. 1986, 69:161-168.
239. Mahoney S.A., Perry M., Seddon A., Bohlen P., Haynes L. Transglutaminase forms midkine homodimers in cerebellar neurons and modulates the neurite-outgrowth response. Biochem. Biophys. Res. Commun. 1996, 224:147-152.
240. Maiuri L., Luciani A., Giardino I., Raia V., Villella V.R., D'Appolito M., et al. Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. J. Immunol. 2008, 180:7697-7705.
241. Malorni W., Farrace M.G., Rodolfo C., Piacentini M. Type 2 transglutaminase in neurodegenerative diseases: the mitochondrial connection. Curr. Pharm. Des. 2008, 14:278-288.
242. Malorni W., Farrace M.G., Matarrese P., Tinari A., Ciarlo L., Mousavi-Shafaei P., et al. The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis. Cell Death Differ. 2009, 16:1480-1492.
243. Mangala L.S., Arun B., Sahin A.A., Mehta K. Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion. Mol. Cancer 2005, 4:33.
244. Mangala L.S., Fok J.Y., Zorrilla-Calancha I.R., Verma A., Mehta K. Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 2007, 26:2459-2470.
245. Mann A.P., Verma A., Sethi G., Manavathi B., Wang H., Fok J.Y., et al. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. Cancer Res. 2006, 66:8788-8795.
246. Mariani P., Carsughi F., Spinozzi F., Romanzetti S., Meier G., Casadio R., et al. Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data. Biophys. J. 2000, 78:3240-3251.
247. Martinez J., Chalupowicz D.G., Roush R.K., Sheth A., Barsigian C. Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry 1994, 33:2538-2545.
248. Mastroberardino P.G., Piacentini M. Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential. J. Intern. Med. 2010, 268:419-431.
249. Mastroberardino P.G., Farrace M.G., Viti I., Pavone F., Fimia G.M., Melino G., et al. " Tissue" transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes. Biochim. Biophys. Acta 2006, 1757:1357-1365.
250. Matic I., Sacchi A., Rinaldi A., Melino G., Khosla C., Falasca L., et al. Characterization of transglutaminase type II role in dendritic cell differentiation and function. J. Leukoc. Biol. 2010, 88:181-188.
251. McConoughey S.J., Basso M., Niatsetskaya Z.V., Sleiman S.F., Smirnova N.A., Langley B.C., et al. Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Mol. Med. 2010, 9:349-370.
252. Mehta K. Biological and therapeutic significance of tissue transglutaminase in pancreatic cancer. Amino Acids 2009, 36:709-716.
253. Mehta K., Lopez-Berestein G., Moore W.T., Davies P.J. Interferon-gamma requires serum retinoids to promote the expression of tissue transglutaminase in cultured human blood monocytes. J. Immunol. 1985, 134:2053-2056.
254. Mehta K., Fok J.Y., Mangala L.S. Tissue transglutaminase: from biological glue to cell survival cues. Front. Biosci. 2006, 11:173-185.
255. Mehta K., Kumar A., Kim H.I. Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem. Pharmacol. 2010, 80:1921-1929.
256. Merz D., Liu R., Johnson K., Terkeltaub R. IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation. J. Immunol. 2003, 171:4406-4415.
257. Meulmeester E., Melchior F. Cell biology: SUMO. Nature 2008, 452:709-711.
258. Mhaouty-Kodja S. Gha/tissue transglutaminase 2: an emerging G protein in signal transduction. Biol. Cell 2004, 96:363-367.
259. Mian S., el Alaoui S., Lawry J., Gentile V., Davies P.J., Griffin M. The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression. FEBS Lett. 1995, 370:27-31.
260. Milakovic T., Tucholski J., McCoy E., Johnson G.V. Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J. Biol. Chem. 2004, 279:8715-8722.
261. Mirza A., Liu S.L., Frizell E., Zhu J., Maddukuri S., Martinez J., et al. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am. J. Physiol. 1997, 272:G281-G288.
262. Mishra S., Murphy L.J. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J. Biol. Chem. 2004, 279:23863-23868.
263. Mishra S., Murphy L.J. The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem. Biophys. Res. Commun. 2006, 339:726-730.
264. Mishra S., Murphy L.J. Phosphorylation of transglutaminase 2 by PKA at Ser216 creates 14-3-3 binding sites. Biochem. Biophys. Res. Commun. 2006, 347:1166-1170.
265. Mishra S., Saleh A., Espino P.S., Davie J.R., Murphy L.J. Phosphorylation of histones by tissue transglutaminase. J. Biol. Chem. 2006, 281:5532-5538.
266. Mishra S., Melino G., Murphy L.J. Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein. J. Biol. Chem. 2007, 282:18108-18115.
267. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
268. Monsonego A., Shani Y., Friedmann I., Paas Y., Eizenberg O., Schwartz M. Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes. J. Biol. Chem. 1997, 272:3724-3732.
269. Monsonego A., Friedmann I., Shani Y., Eisenstein M., Schwartz M. GTP-dependent conformational changes associated with the functional switch between Galpha and cross-linking activities in brain-derived tissue transglutaminase. J. Mol. Biol. 1998, 282:713-720.
270. Murtaugh M.P., Mehta K., Johnson J., Myers M., Juliano R.L., Davies P.J. Induction of tissue transglutaminase in mouse peritoneal macrophages. J. Biol. Chem. 1983, 258:11074-11081.
271. Murtaugh M.P., Dennison O., Stein J.P., Davies P.J. Retinoic acid-induced gene expression in normal and leukemic myeloid cells. J. Exp. Med. 1986, 163:1325-1330.
272. Myrsky E., Kaukinen K., Syrjanen M., Korponay-Szabo I.R., Maki M., Lindfors K. Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis. Clin. Exp. Immunol. 2008, 152:111-119.
273. Nadalutti C., Viiri K.M., Kaukinen K., Maki M., Lindfors K. Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis. Cell Prolif. 2011, 44:49-58.
274. Nagy L., Saydak M., Shipley N., Lu S., Basilion J.P., Yan Z.H., et al. Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 1996, 271:4355-4365.
275. Nakano Y., Addison W.N., Kaartinen M.T. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures. Bone 2007, 41:549-561.
276. Nakano Y., Forsprecher J., Kaartinen M.T. Regulation of ATPase activity of transglutaminase 2 by MT1-MMP: implications for mineralization of MC3T3-E1 osteoblast cultures. J. Cell. Physiol. 2010, 223:260-269.
277. Nakaoka H., Perez D.M., Baek K.J., Das T., Husain A., Misono K., et al. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 1994, 264:1593-1596.
278. Nanda N., Iismaa S.E., Owens W.A., Husain A., Mackay F., Graham R.M. Targeted inactivation of Gh/tissue transglutaminase II. J. Biol. Chem. 2001, 276:20673-20678.
279. Nelea V., Nakano Y., Kaartinen M.T. Size distribution and molecular associations of plasma fibronectin and fibronectin crosslinked by transglutaminase 2. Protein J. 2008, 27:223-233.
280. Nemes Z., Fesus L., Egerhazi A., Keszthelyi A., Degrell I.M. N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia. Neurobiol. Aging 2001, 22:403-406.
281. Nemes Z., Petrovski G., Csosz E., Fesus L. Structure-function relationships of transglutaminases-a contemporary view. Prog. Exp. Tumor Res. 2005, 38:19-36.
282. Nemes Z., Petrovski G., Aerts M., Sergeant K., Devreese B., Fesus L. Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies. J. Biol. Chem. 2009, 284:27252-27264.
283. Nickel W., Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 2009, 10:148-155.
284. Nishimichi N., Higashikawa F., Kinoh H.H., Tateishi Y., Matsuda H., Yokosaki Y. Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding site. J. Biol. Chem. 2009, 284:14769-14776.
285. Nishimichi N., Hayashita-Kinoh H., Chen C., Matsuda H., Sheppard D., Yokosaki Y. Osteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1. J. Biol. Chem. 2011, 286:11170-11178.
286. Nunes I., Gleizes P.E., Metz C.N., Rifkin D.B. Latent transforming factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J. Cell Biol. 1997, 136:1151-1163.
287. Nurminskaya M., Kaartinen M.T. Transglutaminases in mineralized tissues. Front. Biosci. 2006, 11:1591-1606.
288. Nurminskaya M., Linsenmayer T.F. Identification and characterization of up-regulated genes during chondrocyte hypertrophy. Dev. Dyn. 1996, 206:260-271.
289. Nurminskaya M., Magee C., Faverman L., Linsenmayer T.F. Chondrocyte-derived transglutaminase promotes maturation of preosteoblasts in periosteal bone. Dev. Biol. 2003, 263:139-152.
290. Nurminsky D., Shanmugasundaram S., Deasey S., Michaud C., Allen S., Hendig D., et al. Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis. Mech. Dev. 2011, 128:234-245.
291. Oliverio S., Amendola A., Di Sano F., Farrace M.G., Fesus L., Nemes Z., et al. Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol. Cell. Biol. 1997, 17:6040-6048.
292. Orban J.M., Wilson L.B., Kofroth J.A., El-Kurdi M.S., Maul T.M., Vorp D.A. Crosslinking of collagen gels by transglutaminase. J. Biomed. Mater. Res. 2004, 68:756-762.
293. Orru S., Caputo I., D'Amato A., Ruoppolo M., Esposito C. Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line. Implications for celiac disease. J. Biol. Chem. 2003, 278:31766-31773.
294. Ozpolat B., Akar U., Mehta K., Lopez-Berestein G. PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells. Autophagy 2007, 3:480-483.
295. Palecek S.P., Loftus J.C., Ginsberg M.H., Lauffenburger D.A., Horwitz A.F. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 1997, 385:537-540.
296. Pan J., Kao Y.L., Joshi S., Jeetendran S., Dipette D., Singh U.S. Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Neurochem. 2005, 93:571-583.
297. Park H., Won J.H., Han K.J., Suh P.G., Ryu S.H., Lee H.S., et al. Phospholipase C-δ1 and oxytocin receptor signaling: evidence of its role as an effector. Biochem. J. 1998, 331:283-289.
298. Park H., Park E.S., Lee H.S., Yun H.Y., Kwon N.S., Baek K.J. Distinct characteristic of Galpha(h) (transglutaminase II) by compartment: GTPase and transglutaminase activities. Biochem. Biophys. Res. Commun. 2001, 284:496-500.
299. Park D., Choi S.S., Ha K.S. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 2010, 39:619-631.
300. Parsons M., Keppler M.D., Kline A., Messent A., Humphries M.J., Gilchrist R., et al. Site-directed perturbation of protein kinase C-integrin interaction blocks carcinoma cell chemotaxis. Mol. Cell. Biol. 2002, 22:5897-5911.
301. Paulmann N., Grohmann M., Voigt J.P., Bert B., Vowinckel J., Bader M., et al. Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 2009, 7:e1000229.
302. Peng X., Zhang Y., Zhang H., Graner S., Williams J.F., Levitt M.L., et al. Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3. FEBS Lett. 1999, 446:35-39.
303. Piacentini M., Ceru M.P., Dini L., Di Rao M., Piredda L., Thomazy V., et al. In vivo and in vitro induction of 'tissue' transglutaminase in rat hepatocytes by retinoic acid. Biochim. Biophys. Acta 1992, 1135:171-179.
304. Piacentini M., Annicchiarico-Petruzzelli M., Oliverio S., Piredda L., Biedler J.L., Melino E. Phenotype-specific " tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int. J. Cancer 1992, 52:271-278.
305. Piacentini M., Farrace M.G., Piredda L., Matarrese P., Ciccosanti F., Falasca L., et al. Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J. Neurochem. 2002, 81:1061-1072.
306. Pietenpol J.A., Stewart Z.A. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 2002, 181-182:475-481.
307. Pinkas D.M., Strop P., Brunger A.T., Khosla C. Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol. 2007, 5:e327.
308. Porzio O., Massa O., Cunsolo V., Colombo C., Malaponti M., Bertuzzi F., et al. Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online. Hum. Mutat. 2007, 28:1150.
309. Pouyssegur J., Dayan F., Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437-443.
310. Priglinger S.G., Alge C.S., Neubauer A.S., Kristin N., Hirneiss C., Eibl K., et al. TGF-beta2-induced cell surface tissue transglutaminase increases adhesion and migration of RPE cells on fibronectin through the gelatin-binding domain. Invest. Ophthalmol. Vis. Sci. 2004, 45:955-963.
311. Radek J.T., Jeong J.M., Murthy S.N., Ingham K.C., Lorand L. Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin. Proc. Natl. Acad. Sci. USA 1993, 90:3152-3156.
312. Riley N.E., Li J., Worrall S., Rothnagel J.A., Swagell C., van Leeuwen F.W., et al. The Mallory body as an aggresome: in vitro studies. Exp. Mol. Pathol. 2002, 72:17-23.
313. Ritter S.J., Davies P.J. Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 1998, 273:12798-12806.
314. Rodolfo C., Mormone E., Matarrese P., Ciccosanti F., Farrace M.G., Garofano E., et al. Tissue transglutaminase is a multifunctional BH3-only protein. J. Biol. Chem. 2004, 279:54783-54792.
315. Rose D.M., Sydlaske A.D., Agha-Babakhani A., Johnson K., Terkeltaub R. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils. Arthritis Rheum. 2006, 54:3363-3371.
316. Sane D.C., Kontos J.L., Greenberg C.S. Roles of transglutaminases in cardiac and vascular diseases. Front. Biosci. 2007, 12:2530-2545.
317. Santhanam L., Tuday E., Webb A., Dowzicky P., Kim J.H., Oh Y.J., et al. Decreased S-nitrosylation of tissue transglutaminase by endothelial nitric oxide synthase contributes to age-related increases in vascular stiffness. Circ. Res. 2010, 107:117-125.
318. Sarang Z., Molnar P., Nemeth T., Gomba S., Kardon T., Melino G., et al. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice. Hepatology 2005, 42:578-587.
319. Sarang Z., Toth B., Balajthy Z., Koroskenyi K., Garabuczi E., Fesus L., et al. Some lessons from the tissue transglutaminase knockout mouse. Amino Acids 2009, 36:625-631.
320. Satpathy M., Cao L., Pincheira R., Emerson R., Bigsby R., Nakshatri H., et al. Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase. Cancer Res. 2007, 67:7194-7202.
321. Satpathy M., Shao M., Emerson R., Donner D.B., Matei D. Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity. J. Biol. Chem. 2009, 284:15390-15399.
322. Scarpellini A., Germack R., Lortat-Jacob H., Muramatsu T., Billett E., Johnson T., et al. Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2. J. Biol. Chem. 2009, 284:18411-18423.
323. Schmid A.W., Condemi E., Tuchscherer G., Chiappe D., Mutter M., Vogel H., et al. Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregation. J. Biol. Chem. 2011, 286:12172-12188.
324. Schuppan D., Junker Y., Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137:1912-1933.
325. Shan L., Molberg O., Parrot I., Hausch F., Filiz F., Gray G.M., et al. Structural basis for gluten intolerance in celiac sprue. Science 2002, 297:2275-2279.
326. Shanmugasundaram S., Logan-Mauney S., Burgos K., Nurminskaya M. Tissue transglutaminase regulates chondrogenesis in mesenchymal stem cells on collagen type XI matrices. Amino Acids 2011, PMID: 21830118.
327. Shao M., Cao L., Shen C., Satpathy M., Chelladurai B., Bigsby R.M., et al. Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Res. 2009, 69:9192-9201.
328. Shibuya H., Sakai K., Kabir-Salmani M., Wachi Y., Iwashita M. Polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) potentiates IGF-I actions in placenta. J. Cell. Physiol. 2011, 226:434-439.
329. Shimada J., Suzuki Y., Kim S.J., Wang P.C., Matsumura M., Kojima S. Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif. Mol. Endocrinol. 2001, 15:1677-1692.
330. Shin D.M., Jeon J.H., Kim C.W., Cho S.Y., Kwon J.C., Lee H.J., et al. Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J. Biol. Chem. 2004, 279:15032-15039.
331. Siegel M., Khosla C. Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol. Ther. 2007, 115:232-245.
332. Siegel M., Strnad P., Watts R.E., Choi K., Jabri B., Omary M.B., et al. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One 2008, 3:e1861.
333. Signorini M., Bortolotti F., Poltronieri L., Bergamini C.M. Human erythrocyte transglutaminase: purification and preliminary characterisation. Biol. Chem. Hoppe Seyler 1988, 369:275-281.
334. Singh U.S., Cerione R.A. Biochemical effects of retinoic acid on GTP-binding protein/transglutaminases in HeLa cells. Stimulation of GTP-binding and transglutaminase activity, membrane association, and phosphatidylinositol lipid turnover. J. Biol. Chem. 1996, 271:27292-27298.
335. Singh U.S., Erickson J.W., Cerione R.A. Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry 1995, 34:15683-15691.
336. Singh U.S., Kunar M.T., Kao Y.L., Baker K.M. Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. EMBO J. 2001, 20:2413-2423.
337. Singh U.S., Pan J., Kao Y.L., Joshi S., Young K.L., Baker K.M. Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Biol. Chem. 2003, 278:391-399.
338. Skalski M., Yi Q., Kean M.J., Myers D.W., Williams K.C., Burtnik A., et al. Lamellipodium extension and membrane ruffling require different SNARE-mediated trafficking pathways. BMC Cell Biol. 2010, 11:62-78.
339. Slaughter T.F., Achyuthan K.E., Lai T.S., Greenberg C.S. A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate. Anal. Biochem. 1992, 205:166-171.
340. Small K., Feng J.F., Lorenz J., Donnelly E.T., Yu A., Im M.J., et al. Cardiac specific overexpression of transglutaminase II (G(h)) results in a unique hypertrophy phenotype independent of phospholipase C activation. J. Biol. Chem. 1999, 274:21291-21296.
341. Sollid L.M. Molecular basis of celiac disease. Annu. Rev. Immunol. 2000, 18:53-81.
342. Sollid L.M., Jabri B. Is celiac disease an autoimmune disorder?. Curr. Opin. Immunol. 2005, 17:595-600.
343. Song H., Chang W., Lim S., Seo H.S., Shim C.Y., Park S., et al. Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells. Stem Cells 2007, 25:1431-1438.
344. Spurlin T.A., Bhadriraju K., Chung K.H., Tona A., Plant A.L. The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling. Biomaterials 2009, 30:5486-5496.
345. Stamnaes J., Fleckenstein B., Sollid L.M. The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim. Biophys. Acta 2008, 1784:1804-1811.
346. Stamnaes J., Pinkas D.M., Fleckenstein B., Khosla C., Sollid L.M. Redox regulation of transglutaminase 2 activity. J. Biol. Chem. 2010, 285:25402-25409.
347. Stephens P., Grenard P., Aeschlimann P., Langley M., Blain E., Errington R., et al. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J. Cell Sci. 2004, 117:3389-3403.
348. Strnad P., Harada M., Siegel M., Terkeltaub R.A., Graham R.M., Khosla C. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement. Gastroenterology 2007, 132:1515-1526.
349. Sugimura Y., Hosono M., Wada F., Yoshimura T., Maki M., Hitomi K. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. J. Biol. Chem. 2006, 281:17699-17706.
350. Szondy Z., Sarang Z., Molnar P., Nemeth T., Piacentini M., Mastroberardino P.G., et al. Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc. Natl. Acad. Sci. USA 2003, 100:7812-7817.
351. Szondy Z., Mastroberardino P.G., Varadi J., Farrace M.G., Nagy N., Bak I., et al. Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis. Cell Death Differ. 2006, 13:1827-1829.
352. Tanaka K., Yokosaki Y., Higashikawa F., Saito Y., Eboshida A., Ochi M. The integrin α5β1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2. Matrix Biol. 2007, 26:409-418.
353. Tarantino U., Oliva F., Taurisano G., Orlandi A., Pietroni V., Candi E., et al. FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice. Amino Acids 2009, 36:679-684.
354. Tatsukawa H., Kojima S. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis. Cell Biol. Int. 2010, 34:325-334.
355. Tatsukawa H., Fukaya Y., Frampton G., Martinez-Fuentes A., Suzuki K., Kuo T.F., et al. Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology 2009, 136:1783-1795.
356. Tee A.E., Marshall G.M., Liu P.Y., Xu N., Haber M., Norris M.D., et al. Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation. J. Biol. Chem. 2010, 285:3561-3567.
357. Teesalu K., Panarina M., Uibo O., Uibo R., Utt M. Autoantibodies from patients with celiac disease inhibit transglutaminase 2 binding to heparin/heparan sulfate and interfere with intestinal epithelial cell adhesion. Amino Acids 2011, PMID: 21847613.
358. Telci D., Griffin M. Tissue transglutaminase (TG2): a wound response enzyme. Front. Biosci. 2006, 11:867-882.
359. Telci D., Wang Z., Li X., Verderio E.A.M., Humphries M.J., Baccarini M., et al. Fibronectin-TG2 matrix rescues RGD-impaired cell adhesion through syndecan-4 and β1 integrin co-signaling. J. Biol. Chem. 2008, 283:20937-20947.
360. Telci D., Collighan R.J., Basaga H., Griffin M. Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide. J. Biol. Chem. 2009, 284:29547-29558.
361. Thomazy V.A., Davies P.J. Expression of tissue transglutaminase in the developing chicken limb is associated both with apoptosis and endochondral ossification. Cell Death Differ. 1999, 6:146-154.
362. Thomazy V., Fesus L. Differential expression of tissue transglutaminase in human cells. An immunohistochemical study. Cell Tissue Res. 1989, 255:215-224.
363. Toth B., Garabuczi E., Sarang Z., Vereb G., Vamosi G., Aeschlimann D., et al. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J. Immunol. 2009, 182:2084-2092.
364. Toth B., Sarang Z., Vereb G., Zhang A., Tanaka S., Melino G., et al. Over-expression of integrin beta3 can partially overcome the defect of integrin beta3 signaling in transglutaminase 2 null macrophages. Immunol. Lett. 2009, 126:22-28.
365. Tovar-Vidales T., Clark A.F., Wordinger R.J. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells. Exp. Eye Res. 2011, 93:442-451.
366. Tucholski J., Johnson G.V. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. J. Neurochem. 2002, 81:780-791.
367. Tucholski J., Johnson G.V. Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation. J. Biol. Chem. 2003, 278:26838-26843.
368. Tucholski J., Lesort M., Johnson G.V. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 2001, 102:481-491.
369. Turner P.M., Lorand L. Complexation of fibronectin with tissue transglutaminase. Biochemistry 1989, 28:628-635.
370. Upchurch H.F., Conway E., Maxwell M.D. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix-bound enzyme. J. Cell. Physiol. 1991, 149:375-382.
371. van den Akker J., van Weert A., Afink G., Bakker E.N., van der Pol E., Boing A.N., et al. Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation. Amino Acids 2011, PMID: 21830119.
372. van den Brule F.A., Liu F.T., Castronovo V. Transglutaminase-mediated oligomerization of galectin-3 modulates human melanoma cell interactions with laminin. Cell Adhes. Commun. 1998, 5:425-435.
373. van Oostveen J., Bijl J., Raaphorst F., Walboomers J., Meijer C. The role of homeobox genes in normal hematopoiesis and hematological malignancies. Leukemia 1999, 13:1675-1690.
374. Van Strien M.E., Baron W., Bakker E.N., Bauer J., Bol J.G., Breve J.J., et al. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination. Glia 2011, 59:1622-1634.
375. Verderio E.A., Scarpellini A. Significance of the syndecan-4-transglutaminase-2 interaction. Scientific World Journal 2010, 10:1073-1077.
376. Verderio E., Nicholas B., Gross S., Griffin M. Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment and cell death. Exp. Cell Res. 1998, 239:119-138.
377. Verderio E., Gaudry C., Gross S., Smith C., Downes S., Griffin M. Regulation of cell surface tissue transglutaminase: effects on matrix storage of latent transforming growth factor-beta binding protein-1. J. Histochem. Cytochem. 1999, 47:1417-1432.
378. Verderio E., Coombes A., Jones R.A., Li X., Heath D., Downes S., et al. Role of the cross-linking enzyme tissue transglutaminase in the biological recognition of synthetic biodegradable polymers. J. Biomed. Mater. Res. 2001, 54:294-304.
379. Verderio E.A., Telci D., Okoye A., Melino G., Griffin M. A novel RGD-independent cell adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. J. Biol. Chem. 2003, 278:42604-42614.
380. Verderio E.A., Johnson T., Griffin M. Tissue transglutaminase in normal and abnormal wound healing: review article. Amino Acids 2004, 26:387-404.
381. Verderio E.A., Scarpellini A., Johnson T.S. Novel interactions of TG2 with heparan sulfate proteoglycans: reflection on physiological implications. Amino Acids 2009, 36:671-677.
382. Verma A., Mehta K. Tissue transglutaminase-mediated chemoresistance in cancer cells. Drug Resist. Updat. 2007, 10:144-151.
383. Verma A., Wang H., Manavathi B., Fok J.Y., Mann A.P., Kumar R., et al. Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res. 2006, 66:10525-10533.
384. Verma A., Guha S., Wang H., Fok J.Y., Koul D., Abbruzzese J., et al. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin. Cancer Res. 2008, 14:1997-2005.
385. Verma A., Guha S., Diagaradjane P., Kunnumakkara A.B., Sanguino A.M., Lopez-Berestein G., et al. Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer. Clin. Cancer Res. 2008, 14:2476-2483.
386. Vezza R., Habib A., FitzGerald G.A. Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh. J. Biol. Chem. 1999, 274:12774-12779.
387. Vollberg T.M., George M.D., Nervi C., Jetten A.M. Regulation of type I and type II transglutaminase in normal human bronchial epithelial and lung carcinoma cells. Am. J. Respir. Cell Mol. Biol. 1992, 7:10-18.
388. Wajda I., Ginsburg M., Waelsch H. Incorporation of histamine into liver protein in vivo. Nature 1961, 191:1204-1205.
389. Walther D.J., Peter J.U., Winter S., Holtje M., Paulmann N., Grohmann M., et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 2003, 115:851-862.
390. Walther D.J., Stahlberg S., Vowinckel J. Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated posttranslational protein modification to monoaminylation deregulation diseases. FEBS J 2011, PMID: 21923757.
391. Wang Z., Griffin M. TG2, a novel extracellular protein with multiple functions. Amino Acids 2011, PMID: 21818567.
392. Wang Z., Collighan R.J., Gross S.R., Danen E.H., Orend G., Telci D., et al. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 and {alpha}5{beta}1 integrin co-signaling. J. Biol. Chem. 2010, 285:40212-40229.
393. Wang Z., Telci D., Griffin M. Importance of syndecan-4 and syndecan-2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Exp. Cell Res. 2011, 317:367-381.
394. Watts S.W., Priestley J.R., Thompson J.M. Serotonylation of vascular proteins important to contraction. PLoS One 2009, 4:e5682.
395. Wilhelmus M.M., van Dam A.M., Drukarch B. Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur. J. Pharmacol. 2008, 585:464-472.
396. Worthington J.J., Klementowicz J.E., Travis M.A. TGFβ: a sleeping giant awoken by integrins. Trends Biochem. Sci. 2011, 36:47-54.
397. Wu J., Liu S.L., Zhu J.L., Norton P.A., Nojiri S., Hoek J.B., et al. Roles of tissue transglutaminase in ethanol-induced inhibition of hepatocyte proliferation and alpha 1-adrenergic signal transduction. J. Biol. Chem. 2000, 275:22213-22219.
398. Xian X., Gopal S., Couchman J.R. Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res. 2010, 339:31-46.
399. Xu L., Begum S., Hearn J.D., Hynes R.O. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, inhibits melanoma tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 2006, 103:9023-9028.
400. Yamada K.M., Even-Ram S. Integrin regulation of growth factor receptors. Nat. Cell Biol. 2002, 4:E75-E76.
401. Yi S.J., Groffen J., Heisterkamp N. Transglutaminase 2 regulates the GTPase-activating activity of Bcr. J. Biol. Chem. 2009, 284:35645-35651.
402. Yuan L., Siegel M., Choi K., Khosla C., Miller C.R., Jackson E.N., et al. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellualr matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 2007, 26:2563-2573.
403. Zainelli G.M., Ross C.A., Troncoso J.C., Muma N.A. Transglutaminase cross-links in intranuclear inclusions in Huntington disease. J. Neuropathol. Exp. Neurol. 2003, 62:14-24.
404. Zemskov E.A., Janiak A., Hang J., Waghray A., Belkin A.M. The role of tissue transglutaminase in cell-matrix interactions. Front. Biosci. 2006, 11:1057-1076.
405. Zemskov E.A., Mikhailenko I., Strickland D.K., Belkin A.M. Cell surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1. J. Cell Sci. 2007, 120:3188-3199.
406. Zemskov E.A., Loukinova E., Mikhailenko I., Coleman R.A., Strickland D.K., Belkin A.M. Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase. J. Biol. Chem. 2009, 284:16693-16703.
407. Zemskov E.A., Mikhailenko I., Hsia R.C., Zaritskaya L., Belkin A.M. Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes. PLoS One 2011, 6:e19414.
408. Zemskov E.A., Mikhailenko I., Smith E.P., Belkin A.M. Tissue transglutaminase promotes PDGF/PDGFR-mediated signaling and responses in vascular smooth muscle cells. J. Cell. Physiol. 2011, PMID: 21769866.
409. Zhang J., Lesort M., Guttmann R.P., Johnson G.V. Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J. Biol. Chem. 1998, 273:2288-2295.